Helixis, a Carlsbad, CA, biomedical diagnostics startup founded in 2007, has raised $5.5 million in a secondary round that aims to total $6.5 million in venture funding, according to a report in PE Hub. The company says it was created to make advanced molecular diagnostic products more accessible for critical medical and scientific use. Domain Associates, Advanced Technology Ventures, and Okapi Venture Capital led initial venture funding of $10 million. The founders include Nobel Prize winner David Baltimore, a Caltech biology professor, and Alex Scherer, a Caltech professor of electrical engineering, applied physics, and physics.

Comments (1) | Reprints | Share:        

Nexus Biosystems, a four-year-old biotech tools maker in Poway, CA, has raised $5 million in venture funding from Telegraph Hill Partners, a private equity firm based in San Francisco, according to a regulatory filing. Nexus CEO John Lillig, who declined to comment on the filing, told me the company specializes in making automated sample storage and retrieval systems capable of holding millions of compounds. In a statement, Nexus says the funding will be used to accelerate the commericalization of several new products, including a family of machines that store samples at minus-80 degrees Celsius.

Comments | Reprints | Share: